The structural profiles are close, with Exact Sciences carrying a narrow edge on growth. Insmed still has the edge on growth, which keeps the comparison from looking entirely one-sided. On the market side, Exact Sciences is in better shape — its trend is intact while Insmed's trend has broken down. That puts structure and market broadly in agreement — Exact Sciences's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The page question resolves through growth, where Insmed Incorporated holds the stronger read even though the broader score still favours Exact Sciences Corp.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The clearest structural overlap shows up in capital structure and margin trend.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
Insmed Incorporated occupies the cheaper side of the setup map, although Exact Sciences Corp still holds the stronger structural profile.
Valuation position uses Forward P/E where available.
Where EXAS and INSM each sit in their own 4.9-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The main growth separation is very wide, driven by a meaningfully stronger expansion profile.
Insmed Incorporated still looks less cycle-sensitive — that keeps the result from looking completely one-sided.
Growth is the clearest driver of the lead, with valuation adding further support — though growth still provides a real counterweight.
Break down the EXAS vs INSM comparison across all dimensions with the full interactive tool.
Explore how EXAS and INSM each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.